Sen McCain To Hold Press Conference Regarding FDA Supplement Regulations
U.S. Senator John McCain (R-AZ) and others will hold a press conference tomorrow to discuss legislation to improve the Food and Drug Administration’s (FDA) current regulations ensuring all dietary supplements sold over-the-counter, in retail stores and online are safe and effective.
Supplement Safety Now Releases New Video Concerning Supplement Dangers
The United States Anti-Doping Agency (USADA) today launched a public education video called “American Roulette” under its Supplement Safety Now (www.SupplementSafetyNow.com) initiative.
Partnership For Clean Competition Awards More Than $1 Million In Grant Funding
The Partnership for Clean Competition (PCC) – which aims to ensure integrity in sport by supporting high-quality, high-impact, novel research – announced today that it has awarded $1.3 million in grant funding since its inception. The announcement comes after the PCC awarded funding to four new research projects.
USADA Arms Team USA With Key IOC Anti-Doping Rule Education In Preparation For Olympic Games
With less than one month until the 2010 Olympic Winter Games kick-off in Vancouver, British Columbia, the United States Anti-Doping Agency (USADA) is continuing to ensure all members of Team USA are aware of their requirements and responsibilities under the International Olympic Committee’s (IOC) Anti-Doping Rules. USADA’s efforts involve an aggressive educational campaign to provide timely material and necessary resources into the hands of U.S. athletes and their support personnel.
Winter Games Athletes Team Up With USADA To Promote Clean Sport
USADA announces the launch of its “I COMPETE CLEAN because…” campaign, the organization’s fourth clean sport campaign.
Steroid Classification Highlights Need for Action to Protect Consumers
The United States Anti-Doping Agency (USADA) today commended the U.S. Department of Justice Drug Enforcement Administration (DEA) for classifying three steroids as “anabolic steroids” under the Controlled Substances Act (CSA), but warned that the regulatory process is too lengthy and cumbersome to keep pace with the continuing flood of dangerous precursors and steroids being introduced to the market.